Cita APA

Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H., Hemmer, B., . . . Investigators, O. I. C. (2017). Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

Citación estilo Chicago

Hauser, Stephen L., et al. Ocrelizumab Versus Interferon Beta-1a in Relapsing Multiple Sclerosis. 2017.

Cita MLA

Hauser, Stephen L., et al. Ocrelizumab Versus Interferon Beta-1a in Relapsing Multiple Sclerosis. 2017.